Genetherapy

Story Summary: Researchers: HIV virus can hide in bone marrowMarch 7, 2010 By RANDOLPH E. SCHMID , AP Science Writer(AP) — The virus that causes AIDS can hide in the bone marrow, avoiding drugs and later awakening to cause illness, according to new research that could point the way toward better treatments for the disease. Finding that hide-out is a first step, but years of research lie ahead. Dr. Kathleen Collins of the University of Michigan and her colleagues report in this weeks edition of the journal Nature Medicine that the HIV virus can infect long-lived bone marrow cellsthat eventually convert into blood cells. Thats an indication that while the drugs battle the active virus, some of the disease remains hidden away to flare up once the therapy is stopped. Thats critical in countries where the treatment is hard to afford and deliver. I dont know how many people realize that although the drugs have reduced mortality we still have a long way to go, Collins said in a telephone interview. That is mainly because we cant stop the drugs, people have to take it for a lifetime. This material may not be published, broadcast, rewritten or redistributed. stealthc- 16 hours agoit took them this long to figure this out?HIV is in the blood, it infects cells from the immune system, and mysteriously has a hide out spot, why wouldnt it have been the obvious choice a decade and a half ago? The number of members on the largest HIV dating&support site == Positivefish. com (if I spell the site correctly) has reached 500,000 membersOMG! Why so many guys and girls on the site are very sexy? In a study from the Aaron Diamond AIDS Research Center and the Bernard-Nocht Institute appearing in the international open-access . . . 34 minutes ago | not rated yet | 0 (PhysOrg….Read the Full Story

Related posts:

1. University of Michigan scientists discover bone marrow can harbor HIV-infected cells
2. Van Andel Institute researchers find gene that could lead to new therapies for bone marrow disease
3. Gene mismatch influences success of bone marrow transplants

Story Summary: Favorable data from Stage B of this study will position Novavax for possible registration of the 2009 H1N1 VLP pandemic influenza vaccine candidate in Mexico. Novavax has now completed enrollment of the largest clinical trial in the Companys history, said Dr. Rahul Singhvi, President and Chief Executive Officer of Novavax. This was an ambitious program from the start and we now have realized a remarkable milestone in less than five months. About VLPs Virus-like particles (VLPs) mimic the external structure of viruses but lack the live genetic material that causes viral replication and infection. Novavaxs VLP-based vaccine candidates are produced more rapidly than egg-based vaccines by using proprietary, portable, recombinant cell-culture technology. The company produces potent VLP-based recombinant vaccines utilizing new and efficient manufacturing approaches. Novavax is committed to using its VLP technology to create country-specific vaccine solutions. Forward-Looking Statements Statements herein relating to future safety or efficacy results of clinical trials, the impact or influence of such results on registration in Mexico or anywhere else in the world and other expectations regarding clinical trials and development of the 2009 H1N1 vaccine are forward-looking statements within the meaning of the Private Securities Litigation Reform Act. Novavax cautions that these forward-looking statements are subject to numerous assumptions, risks and uncertainties, which change over time. gov. These forward-looking statements speak only as of the date of this press release, and Novavax assumes no duty to update forward-looking statements….Read the Full Story

Related posts:

1. NOVAVAX Completes First Stage Of Enrollment In Pivotal H1N1 Influenza Vaccine Study In The Country Of Mexico
2. NOVAVAX Reports Positive Clinical Results from Pivotal Study of H1N1 Influenza Vaccine in Mexico
3. Novavax, Inc. :: NOVAVAX Announces Publication of a Preclinical Study Demonstrating that a Virus-like Particle Vaccine Provided Protection Against Highly Pathogenic H1N1 and H5N1 Influenza Strains

Story Summary: GeneSightRx(r) measures and analyzes more than forty clinically important genetic variants that affect patients response to medications prescribed in psychiatric medicine. The CYP1A2 gene is involved in the metabolism of a number of commonly used drugs, including antidepressants and antipsychotics. Enhancing our pharmacogenetic test by adding the CYP1A2 gene is an important part of our strategy of serving the behavioral health community with therapeutic decision-support products, said , President and CEO of AssureRx Health. The results of the report can help a doctor understand the way a patients unique genetic makeup may affect certain psychiatric drugs. Quick turnaround time, combined with a customized report of the patients genetic makeup, clinical experience, and other factors can help a physician make personalized drug treatment choices for each individual patient. About AssureRx Health-based AssureRx Health, Inc. is a personalized medicine company that specializes in pharmacogenetics and is dedicated to helping physicians determine the right drug at the right dose for individual patients suffering from psychiatric disorders. The company was founded in to commercialize industry-leading personalized medicine technology. The company was founded in to commercialize industry-leading personalized medicine technology….Read the Full Story

Related posts:

1. Authors of Psychiatric Guidelines Get Funding from Drug Makers – Health Blog – WSJ
2. 454 Life Sciences and Roche NimbleGen Announce Collaboration with Eli Lilly and SeqWright to Sequence Genomic Regions Associated with Psychiatric Disease
3. Genes Linked to Breast Cancer Drug Resistance Could Guide Future Treatment

A record 4.3 million babies were born in the U.S. in 2007, according to a summary of birth statistics published each year in the journal Pediatrics. The birth rate (number of births per 1,000 women) has been climbing for a couple of decades, though it is nowhere near what it was 100 years ago. The record high number of births is due both to a recent trend upward in the birth rate and the larger U.S. population now than 100 years ago.

A noteworthy trend in the data is that women are having their babies later than they did just 15-20 years ago. Birth rates were lower in 2007 than in 1990 for women under 30, but higher in 2007 for women over 30. Also noteworthy is a continued rise in the number of births to unmarried women; it’s now a record 40% of all births.

Story Summary: The findings, which appear online March 7 in Nature Medicine, indicate a new target for curing the disease so those infected with the virus may someday no longer rely on AIDS drugs for a lifetime. Antiviral drugs have been effective at keeping the virus at bay. Infected cells are able to live on, undetected by the immune system, and provide the machinery for the virus to reproduce and spread. While further studies are needed to demonstrate that stem cells can harbor the HIV virus, the study results confirm that HIV targets some long-lived progenitor cells, young cells that have not fully developed but mature into cells with special immune functions. When active infection occurs the toxic effects of the virus kill the cell even as the newly made viral particles spread the infection to new target cells. Our finding that HIV infects these cells has clear ramifications for HIV disease because some of these cells may be long-lived and could carry latent HIV for extended periods of time, she says. The new research gives a broader view of how HIV overwhelms the bodys immune system and devastates its ability to regenerate itself. Globally more than 30 million people are infected with HIV, including millions of children….Read the Full Story

Related posts:

1. Researchers: HIV virus can hide in bone marrow
2. Gene mismatch influences success of bone marrow transplants
3. Adult Bone Marrow Stem Cells Injected into Skeletal Muscle Can Repair Heart Tissue – UB NewsCenter

Story Summary: The findings could be a substantial step toward understanding the very origin of Earthly life, the lead researcher contends. The smallest RNA enzyme ever known to perform a cellular chemical reaction is described in a paper published this week in the Proceedings of the National Academy of Sciences. That pioneering work has been carried on further by Yarus, Blumenthal said. If very simple RNA molecules such as the product of the Yarus lab could have accelerated chemical reactions in Earths primordial stew, the chances are much greater that RNA could direct and accelerate biochemical reactions under primitive conditions. Before the advent of RNA, most biologists believe, there was a simpler world of chemical replicators that could only make more of themselves, given the raw materials of the time, Yarus said. If there exists that kind of mini-catalyst, a sister to the one we describe, the world of the replicators would also jump a long step closer and we could really feel we were closing in on the first things on Earth that could undergo Darwinian evolution, Yarus said. Dr Yarus has brought an innovative approach to bear on the key question of how complex processes originated, said Michael Bender, a biologist who oversees protein synthesis grants at the National Institutes of Healths National Institute of General Medical Sciences. — full story– 23 July 2009A small green beetle may have some interesting lessons to teach scientists about optics and liquid crystals – complex mechanisms the insect uses to create a shell so strikingly beautiful. — full story– 9 July 2009Although the fact that we generate new brain cells throughout life is no longer disputed, their purpose has been the topic of much debate. — full story– 9 July 2009Although the fact that we generate new brain cells throughout life is no longer disputed, their purpose has been the topic of much debate. Now, an international collaboration of researchers. — full story– 8 July 2009The Wildlife Conservation Society (WCS) announced today the discovery of a new monkey in a remote region of the Amazon in Brazil….Read the Full Story

Related posts:

1. Scientists Create Tiny RNA Molecule With Big Implications
2. Technique finds gene regulatory sites without knowledge of regulators
3. New UBC sequencing technique could boost pine beetle fight, improve cancer research

Story Summary: RegeneMed is a preferred provider of primary hepatocyte cultures and services. This enables high-content, high-throughput application of the current in vivo-based ToxFX(r)platform to in vitrodata using iToxFX. Key advantages of iToxFX include: Screening compounds more rapidly and cost-effectively than conventional animal studies Testing a large number of candidate drugs from one hepatocyte preparation Automatically generating comprehensive analysis reports for each drug, reducing a task that traditionally takes weeks down to mere minutes iToxFX leverages Entelos powerful DrugMatrix(r), a reference database comprised of Entelos-generated data from over 18,000 vehicle and drug-treated animal tissue samples and cultures, based on 600 marketed drugs and toxicology standards. Toxicogenomics is the science of applying gene expression profiling to understanding mechanisms of toxicity. Entelos provides customized products, technology and research services to global pharmaceutical, health-care, and consumer products companies in safety testing, arthritis, cardiovascular diseases, asthma, obesity, diabetes, hematopoeisis (anemia), cholesterol metabolism, skin sensitization, and personal care products. RegeneMed accelerates the development of safer, more effective drugs by providing three-dimensional, human and animal tissue cultures in high throughput and high content platforms to serve as more physiologically relevant replacements to current industry-standard animal and cell-based tests that have limited human drug toxicity prediction….Read the Full Story

Related posts:

1. Newswise Medical News | New Approach Promises Greater Success for Predicting Drug Safety
2. WaferGen To Introduce New Service For Gene-Expression Profiling Using The SmartChip(TM) Real-Time PCR System
3. U.N. says millions still lack access to AIDS drugs

Story Summary: From 2005 to 2007, he was the founder and President of DX Innovations, Inc. , a market research company which focused on providing technical solutions for companies in the molecular diagnostics marketplace. Dr. Braun has over 21 Issued Patents and Published Applications and has authored more than 80 peer-reviewed publications. With its headquarters and product development in San Diego, California, TrovaGene has focused on development of tests using its patented transrenal nucleic acid technology. Transrenal DNA (Tr-DNA) and RNA (Tr-RNA) are short nucleic acid fragments from normal cell death that cross the kidney barrier and can be detected in urine. It has issued U. S. and European patents that cover any and all testing for molecular targets that pass through the kidney. This patent position rivals the importance of the Roche PCR and Gen-Probe ribosomal RNA patents in the molecular diagnostic field. This patent position rivals the importance of the Roche PCR and Gen-Probe ribosomal RNA patents in the molecular diagnostic field. Statements about TrovaGenes expectations, applications of its technology, markets, and other statements that are not historical facts are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 and are based on managements current beliefs, assumptions, estimates and projections. Statements about TrovaGenes expectations, applications of its technology, markets, and other statements that are not historical facts are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 and are based on managements current beliefs, assumptions, estimates and projections….Read the Full Story

Related posts:

1. EGEN, Inc. :: EGEN, Inc. Announces the Promotion of Khursheed Anwer, Ph.D., to President and Chief Scientific Officer
2. Santaris Pharma A/S Expands Executive Team, Appoints Chief Medical Officer and Chief Business Officer to Advance Proprietary RNA-targeted Drug Development Programs
3. GeoVax Labs, Inc. Announces Appointment of Mark J. Newman, Ph.D. as Vice President, Research and Development

Lumixyl™ Brightening System

A New Physician-Grade System Designed to Safely Address the Signs of Hyperpigmentation

New York, NY—Envy Medical, Inc., introduces the new Lumixyl™ Brightening System, a revolutionary multi-faceted approach to effectively treat hyperpigmentation without irritation or other side effects associated with prescription Hydroquinone or retinoids. This professional skincare system introduction builds on the success of the Lumixyl Topical Brightening Crème introduced in 2009.

“The Lumixyl Topical Brightening System is an entirely new approach to naturally brighter, more vibrant skin, representing a new physician-grade standard in skincare,” explains Dr. Basil Hantash, MD, PhD, a board certified Stanford-trained dermatologist and vice-chairman of the board at Envy Medical, who also helped develop the Lumixyl peptide technology.

Dr. Hantash

An innovation in skin brightening technology, the four products in the Lumixyl Brightening System work synergistically to target existing hyperpigmentation and to prevent its recurrence. For most patients these formulations can eliminate the need to use hydroquinone or its bi-products, which are controversial due to their potential side effects. Lumixyl products are proven to be powerful but gentle on skin.

“Physicians and the public at large have been calling for a viable alternative to prescription hydroquinone therapies,” commented Envy Medical CEO, Curtis A. Cluff. “We are very pleased to be able to answer that call with a system that provides visible brightening with a safe and non-irritating formula.”

The Lumixyl Topical Brightening System builds on the four products including Active-Prep Cleanser, the Topical Brightening Creme, GlycoPeel 20 Rapid Exfoliating Lotion, and Moisture-Lock Sunscreen SPF 30. The products are ideal for all skin types. Lumixyl Brightening System retails for $270 for four full size products.

Developed by Envy Medical, Inc. and dermatological researchers at Stanford University, Lumixyl products are made exclusively for dermatologists, plastic surgeons and skin oriented aesthetic physicians. The products are manufactured and sold by Envy Medical in the United States and distributed internationally by Toronto Canada-based Basis Medical Technologies.

About BASIS
BASIS Medical Technologies specializes in the development and distribution of groundbreaking technologies in medicine and medical aesthetics. Headquartered in Toronto, Canada, BASIS is an innovative technology platform with sales, marketing and training capabilities around the world. With an experienced management team and medical advisory panel, BASIS is committed to delivering and developing cutting-edge medical products internationally. Basis is an exclusive market representative for Lumixyl in markets throughout the world, a product licensed by Envy Medical Inc.

About Envy Medical
Envy Medical develops, markets and sells highly effective non-invasive skin rejuvenation therapies for patients suffering from either dermatologic or aesthetic conditions. The Company’s lead products include SilkPeel®, a breakthrough device combining exfoliation with dermalinfusion® for deeper tissue delivery of active ingredients and better patient outcomes. Envy is also the exclusive licensor of skin brightening peptides including Lumixyl, developed at Stanford University. The Lumixyl peptide is now also available as a topical solution for SilkPeel procedures, addressing hyperpigmentation and photo-damage.

Envy Medical
888.848.3633
www.envymedical.com

Source: Envy Medical

Story Summary: A research project in the Academy of Finlands Research Program on Nutrition, Food and Health (ELVIRA) has brought new knowledge on the hereditary nature of gluten intolerance and identified genes that carry a higher risk of developing the condition. Research has shown that the genes in question are closely linked with the human immune system and the occurrence of inflammations, rather than being connected with the actual breakdown of gluten in the digestive tract. This is essential, because the condition is often relatively symptom-free, yet it can have serious complications unless treated. The research will be published in a forthcoming issue of Nature Genetics. Gluten intolerance is an autoimmune reaction in the small intestine. The gluten that occurs naturally in grains such as wheat, barley and rye causes damage to the intestinal villi, problems with nutrient absorption and potentially other problems too. Gluten intolerance is an inherited predisposition, and nearly all sufferers carry the genes that play a key part in the onset of the condition. The only known effective treatment is a lifelong gluten-free diet. Journal Reference:Dubois et al. Multiple common variants for celiac disease influencing immune gene expression….Read the Full Story

Related posts:

1. University Of The Basque Country Researcher Studies Genes Associated With Celiac Disease
2. Scientists to trial world first coeliac vaccine – ABC News (Australian Broadcasting Corporation)
3. New Risk Factor for Second-Most-Common Form of Early-Onset Dementia

Story Summary: People with EoE frequently have difficulty eating or may be allergic to one or more foods. This study further suggests that a suspected so-called master allergy gene may play a role in the development of this rare but debilitating disorder. Little is known about what causes EoE, but the disease runs in families suggesting that specific genes may be involved. This type of study detects markers of genetic variation across the entire human genome and allows researchers to zero in on a region of a chromosome to identify genes that influence health and the development of disease. In this study, the investigators identified changes in genes within a region on chromosome 5 that were highly associated with EoE. One of the genes in this region encodes a protein called thymic stromal lymphopoietin (TSLP). TSLP is made by epithelial cells, which line internal and external surfaces of the body. It has already been described as a master switch that may turn on other allergic diseases, such as asthma and atopic dermatitis (eczema). Future research is needed to determine if these findings might lead to a genetic test for TSLP and whether drugs that block the production or function of TSLP might be useful in treating EoE. ARTICLE: ME Rothenberg et al. Common variants at 5q22 associate with pediatric eosinophilic esophagitis. The Institutes research interests include: diabetes and other endocrine and metabolic diseases; digestive diseases, nutrition, and obesity; and kidney, urologic and hematologic diseases. gov. The National Institutes of Health (NIH)The Nations Medical Research Agencyincludes 27 Institutes and Centers and is a component of the U. S. Department of Health and Human Services. For more information about NIH and its programs, visit www. For more information about NIH and its programs, visit www….Read the Full Story

Related posts:

1. NIAID media availability: New strategy proposed for designing antibody-based HIV vaccine
2. Gene Site Found for a Childrens Food Allergy
3. UCLA scientists identify gene linked to deadly disorder in newborns

Story Summary: Only recently recognized as a distinct condition, EoE, like other allergies, has been increasing over the past 20 years, and its reported incidence of one in 10,000 people may be an underestimate. The hallmark of EoE is swelling and inflammation in the esophagus, accompanied by high levels of immune cells called eosinophils. It can affect people of any age, but is more common among young men who have a history of other allergic diseases such as asthma and eczema. They then replicated the initial findings with additional DNA samples from EoE patients and controls at CHOP. TLSP holds the genetic code to produce a cytokine, a specific signaling protein that regulates inflammatory responses occurring in allergic diseases. Physicians then perform tests to determine which foods a child can or cannot eat. Eosinophilic esophagitis is a highly allergic disease, and one that is rapidly expanding, said allergist Jonathan M. Spergel, M. D. , a co-first author of the study, who sees large numbers of patients with EoE as director of the Center for Pediatric Eosinophilic Disorders at The Childrens Hospital of Philadelphia. Its pediatric research program is among the largest in the country, ranking second in National Institutes of Health funding. In addition, its unique family-centered care and public service programs have brought the 441-bed hospital recognition as a leading advocate for children and adolescents. Keywords:Contact InformationAvailable for logged-in reporters onlyDescriptionPediatrics researchers have identified the first major gene location responsible for a severe, often painful type of food allergy called eosinophilic esophagitis (EoE). Keywords:Contact InformationAvailable for logged-in reporters onlyDescriptionPediatrics researchers have identified the first major gene location responsible for a severe, often painful type of food allergy called eosinophilic esophagitis (EoE)….Read the Full Story

Related posts:

1. NIAID media availability: Food allergy-related disorder linked to master allergy gene
2. Immunologist at Childrens Hospital Receives Daland Prize for Patient-Oriented Research
3. Do Women Need Such Big Flu Shots?

Five hours or less of sleep a night corresponds to large increases in visceral fat.

More…

Rush University (US) researchers find that older men and women who maintain a purpose in life are less likely to develop Alzheimer’s Disease.

More…

Ugg… what a pain.  The reaction I’m doing today produces a low molecular weight, light-sensitive ?,?-unsaturated ketone as a product.  It’s a derivative of methyl vinyl ketone.  Not only is it low-boiling, it also polymerizes upon standing in light.  Ugg…

Now, I’ve worked with light-sensitive reagents (like the iodomethane and methallyl iodide) before, so I’m comfortable turning off the light and covering the reaction with foil to keep out extraneous photons.  That’s not so bad, because when the reaction’s done, you can flip on the light to work up the reaction.

Not so when the product is light sensitive.  Gotta keep the light off.  Gotta extract in the dark.  Gotta dry the organic layer with foil around the flask.  Gotta rotovap in the dark with foil around the flask.  Worst of all, gotta run a column in the dark.  For that, I cut off some of the sides of a cardboard box and used them as a shield to block the light and holed myself up in the dark corner of my hood to run the column.  Then gotta rotovap the fractions corresponding to product in the dark in foil.  Take the mass in the dark…  Ugg.  Pain all around.  Oh yeah, I forgot I gotta keep the NMR samples in the dark while I acquire the spectra, too.

Plus, gotta keep the product away from light until I set up the next reaction (which is going on right now)… and that’s gotta be in the dark.  At least when this reaction’s done, I can turn the lights back on.

Fortunately, the first reaction worked quite well.  I ran two multi-gram reactions side by side in the dark and got quantitative yield on both.

So while I run off to find some vitamin D supplements, tell me what the most operationally painful experiment you’ve set up is.  I’m sure many of you have stories that make mine seem trivial.  What experiment’s the biggest pain to run?  I think any reaction involving FOOF (the most awesome, most onomatopoeic molecular formula evah) has to be up there.

Story Summary: It will allow researchers to measure strand-specific expression across the entire samples transcriptome. D. , Mayo Clinic genomics researcher and corresponding author of the study. This provides us with much more information about alterations during cancer development that could reveal important therapeutic targets. We can more completely understand the relationship between an individuals genome and the alterations to that which result in disease. The urgency of this condition points to the need for more efficient technologies and methods. Head and neck cancers are the sixth most prevalent carcinomas in the world. Information provided by these and continued studies will help to better characterize the molecular basis of cancer development. Others involved in the research include co-first author Rebecca Laborde, Ph. D. ; Yongming Sun, Ph. D. ; all of Life Technologies, Foster City, Calif. The research was supported by Mayo Clinic and Life Technologies. D. ; all of Life Technologies, Foster City, Calif. The research was supported by Mayo Clinic and Life Technologies. The funders had no role in study design, data collection, analysis or publishing. Some authors are or have been employed by Life Technologies, which makes technology and materials used in the study….Read the Full Story

Related posts:

1. Michael J. Fox Foundation awards Mayo Clinic researcher grant to advance Parkinsons research
2. Study shows how normal cells influence tumor growth
3. Mayo Clinic Identifies Two Genes As Potential Therapeutic Targets For Multiple Sclerosis

Story Summary: Park is pushing the frontiers of nanotechnology by developing devices capable of probing and manipulating individual neurons. org/Spitzer-Boahen-ParkSource: James CohenThe Kavli Foundation Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. Improving Health CareImprovements are necessary to make sure Americans get the best quality health care and that money for this care is being spent as effectively as possible. Listen as experts — both in government and in the private sector — describe some of the steps taken to improve the health care system. Meningitis OverviewEach year you hear about small outbreaks of meningitis. Meningitis OverviewEach year you hear about small outbreaks of meningitis. It is highly contagious and sometimes fatal. Learn why the classic symptoms of a high fever and stiff neck shouldnt be ignored. Learn why the classic symptoms of a high fever and stiff neck shouldnt be ignored….Read the Full Story

Related posts:

1. Identification Of Brain Protein For Synapse Development
2. 1.6 Million Euro Grant Awarded To Prof. Kobi Rosenblum For Brain And Memory Research
3. Shedding New Light On Walking

Story Summary: The Vilcek Prizes epitomize the mission of the Vilcek Foundation, which was formed by Jan and Marica Vilcek to honor the contributions of foreign-born individuals in the United States. He sees battles raging within a cells nucleus as genes jockey for evolutionary dominance. These clashes can have a long-term impact on organisms, as they sometimes alter the function of essential genes. His lab showed that host proteins can evolve to defeat viral mimicry, providing yet another nuance to a never-ending arms race between hosts and viruses. His lab hypothesized and is testing the model that such a genetic conflict may recurrently drive the onset of reproductive barriers between recently diverged species. He completed his doctoral work in molecular evolutionary biology at the University of Rochester in Rochester, N. Y. , where, under the mentorship of Tom Eickbush, Ph. D. , he first became intrigued by the study of genetic conflict. Contact Our News EditorsFor any corrections of factual information, or to contact the editors please use our feedback form. Please send any medical news or health news press releases to: These are the most read articles from this news category for the last 6 months: Curry Powder Ingredient Kills Cancer Cells28 Oct 2009Researchers from Ireland and Poland found that curcumin, a compound found in the popular Indian spice turmeric that gives curry powder its distinct yellow colour, killed oesophageal cancer cells in the lab via an. Drinking water, distracting yourself, or substituting healthy food for the food craved can help you get through a craving. Drinking water, distracting yourself, or substituting healthy food for the food craved can help you get through a craving….Read the Full Story

Related posts:

1. Protein study shows evolutionary link between plants, humans
2. Hopeful Monsters: Nothing in Evolution Makes Sense Except in the Light of E. coli (and Shigella) : Mike the Mad Biologist
3. And the Evolutionary Beat Goes On…

Story Summary: The challenge is how to do this quickly when you are dealing with millions of genes. The process involves taking lots and lots of short strips of DNA, assembling them into larger sections, and then comparing them to known sequences stored in reference databases and ruling out those known to belong to the human genome. For this study the researchers used fecal samples from 124 Europeans. The study has also revealed a number of clues about how bacteria manage to survive in the rather unhospitable environment of the human gut. The only way to thrive here is to evolve, and this study has unveiled some interesting clues about how they did this. The researchers found that while individual participants of the study had only about 160 of the 1,000 possible species, about 40 per cent of any one one participants gut flora species was also present in around 50 per cent of the other participants. A human gut microbial gene catalogue established by metagenomic sequencing. Junjie Qin, Ruiqiang Li, Jeroen Raes, Manimozhiyan Arumugam, Kristoffer Solvsten Burgdorf, Chaysavanh Manichanh, Trine Nielsen, Nicolas Pons, Florence Levenez, Takuji Yamada, et al. Nature, 464, 59- 65 (4 March 2010)DOI:10. Contact Our News EditorsFor any corrections of factual information, or to contact the editors please use our feedback form. Please send any medical news or health news press releases to: These are the most read articles from this news category for the last 6 months: Do Genes Play A Role In PTSD? Please send any medical news or health news press releases to: These are the most read articles from this news category for the last 6 months: Do Genes Play A Role In PTSD? Study Of Rwanda Genocide Survivors Suggests Yes26 Feb 2010A study of Rwandan Genocide survivors, some with and some without post traumatic stress disorder or PTSD, suggests that genetic factors influence the relationship between a persons traumatic load, or the number of. Study Of Rwanda Genocide Survivors Suggests Yes26 Feb 2010A study of Rwandan Genocide survivors, some with and some without post traumatic stress disorder or PTSD, suggests that genetic factors influence the relationship between a persons traumatic load, or the number of. If the bleeding cannot be controlled, seek emergency medical care….Read the Full Story

Related posts:

1. DYRK1A Gene May Be One Of Most Influential Factors In Downs Syndrome
2. Vulnerability to post-traumatic stress disorder runs in families, study shows
3. Gut bacteria gene complement dwarfs human genome

Story Summary: Meanwhile, ahead of the WHO panel meeting Tuesday that could begin the process of declaring an official end to the pandemic, TIMEexamines the potential long-term threat from influenza. Though H5N1 has not yet mutated into a more contagious form, despite having had plenty of chances to mix with human flu viruses . . . Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. Coping with Cravings While Losing WeightKnowing how to cope with cravings is an important part of losing weight and maintaining weight loss. Drinking water, distracting yourself, or substituting healthy food for the food craved can help you get through a craving. Other strategies that can help you lose weight are keeping a food diary and avoiding processed foods….Read the Full Story

Related posts:

1. Rice, UT-Austin Team Wins Stimulus Funds To Study Influenza A
2. Illumina Announces Delivery Of The First Genome Through Its Individual Genome Sequencing Service
3. Developing Countries Reassess Need For Donated H1N1 Vaccine

Story Summary: In contrast, induction of cytotoxic T cells, the other effector arm of the adaptive immune system is highly inefficient. To achieve this aim, the consortium will build on in-house technologies developed by the partners. Sanquin has a track record in bringing therapeutic proteins, and in vitro diagnostic and research products to the market and is successfully distributing a substantial product portfolio covering these fields on the international market. Since its foundation in 1913, its primary objective has been to combat cancerby combining patient care, research and education. About the Netherlands Vaccine InstituteThe Netherlands Vaccine Institute (NVI) in Bilthoven reflects more than 100 years of extensive knowledge and experience gained through research and production of vaccines. The NVI is an agency responsible to the Ministry of Health, Welfare and Sport. Contact Our News EditorsFor any corrections of factual information, or to contact the editors please use our feedback form. Please send any medical news or health news press releases to: These are the most read articles from this news category for the last 6 months: Seasonal Vaccine Offers Some Protection Against Swine Flu08 Oct 2009The 2008-2009 seasonal flu vaccine1 provides some protection against swine flu, particularly the most severe forms of the disease, according to preliminary research published today on BMJ. Listen to an infection control expert discuss the new cough etiquette. Flu PreventionOur parents told us to cover our mouths when we cough. Flu PreventionOur parents told us to cover our mouths when we cough. But that might not be the best strategy for flu prevention. But that might not be the best strategy for flu prevention….Read the Full Story

Related posts:

1. FDA Approves Vaccine For Seasonal Influenza
2. FDA Approves Vaccine For Seasonal Influenza
3. NOVARTIS INVESTIGATIONAL ADJUVANTED MF59 PRE-PANDEMIC AVIAN INFLUENZA VACCINE AFLUNOV SHOWS LONG LASTING, BROADLY CROSS-PROTECTIVE IMMUNE RESPONSE :: UNTERNEHMENSNACHRICHTEN

Story Summary: Nickolas Papadopoulos of the Howard Hughes Medical Institute in Baltimore, Maryland, cautions that excluding someone on the basis of mitochondrial DNA (mtDNA) alone might be a mistake. It doesnt mean that you cant use mtDNA, it just means that you have to be careful about who you exclude, says Papadopoulos. Other evidence, like shoes found with the body, suggests that the child was indeed Goodwin. In most cases we werent getting anything but mtDNA, but this technique means we can use more of the bone and as a result pull out more DNA. That should come as welcome news to the thousands of families still waiting to find out about loved ones following conflicts like the Vietnam and second world wars. If you would like to reuse any contentfrom New Scientist, either in print or online, please contact the syndicationdepartment first for permission. adding EDTA and proteinase K to prep a sample for DNA isolation is pretty standard isnt it? We should ask why the rest dont, say Lois Leeand Stephen Bullivant15:30 05 March 2010An inner frame that allows components to slide up and down rails could allow the device to harvest power from its users motion13:56 05 March 2010Several journals will no longer publish research supported by the tobacco industry. Ginny Barbour, the chief editor of one of them, explains why13:36 05 March 2010Far from being silent loners, bacteria are little chatterboxes – when theyre not snooping on us….Read the Full Story

Related posts:

1. Ten days to save hearing after deafening sound
2. Research Calls Forensic DNA Technique Into Question
3. PR-USA.net – Bio-Synthesis, Inc. Unveils Its Latest Step Into the Future of Forensic Science

Story Summary: Some variants mediate universal functions, such as chromosome segregation and DNA repair, and others specialize in organism-specific tasks. Focus on: Genome instabilityThe integrity of the genome is crucial for tumour suppression and the propagation of genomic information to subsequent generations. It was produced by and is freely available thanks to support from Boston Biochem. This special Focuson endocytosis reflects the diversity and complexity of endocytic trafficking processes and their associated machineries. Post-transcriptional control seriesThe regulation of gene expression beyond the level of transcription is much more intricate than previously thought, and involves diverse mechanisms that regulate the processing, stability and localization of RNA species. In this new article series, we assess the basic mechanisms of post-transcriptional control and the interplay between them. This special Focusreflects our current understanding of mechanotransduction — from how cells sense mechanical forces in different tissues to how these mechanical forces are transduced into biochemical signals — in development and disease. Poster on Pluripotent cell isolation for regenerative medicinePluripotent cells offer great promise for regenerative medicine. In this Poster, Christopher Lengner and Rudolf Jaenisch compare and contrast the properties of pluripotent embryonic stem cells with those of laboratory-generated pluripotent cells. Web Focus CollectionPlease visit our archive of selected articles from the Nature Publishing Group on key current topics. 2008 Journal Citation Report(Thomson Reuters, 2009)TopExtra navigationNature Publishing Group New York, New York University of Cincinnati Department of Cancer and Cell Biology Vontz Center for Molecular Studies, 3125 Eden Avenue, Cincinnati, OH 45267-0521 Paterson Institute for Cancer Research Manchester United Kingdom Ulm University Hospital 89075 Ulm, Germany The Babraham Institute Cambridge, CB22 3AT, UK The Seeker is looking for novel approaches to increase chemical stability and delivery of small RNA . . ….Read the Full Story

Related posts:

1. News: Nature Reviews Molecular Cell Biology: Focus on endocytosis
2. Stem cell research: From molecular physiology to therapeutic applications
3. Reviews Of Microbial Gene Language Published In Special Issue Of Trends In Microbiology

Story Summary: Professor Brown said the next step of the research, which was recently published in Nature Genetics,was to identify more of the genes associated with the disease. He said the work had also led them to identify similarities between the genes that cause AS and those involved in inflammatory bowel diseases and psoriasis. In combination these conditions affect about three percent of Australians. SourceUniversity of QueenslandAny medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. Please send any medical news or health news press releases to: These are the most read articles from this news category for the last 6 months: Higher Risk Of Knee Arthritis Linked To Too Much Exercise30 Nov 2009A new study by radiologists found that middle-aged men and women who do lots of exercise, and particularly high impact activities like running and jumping, may be unknowingly causing damage to their knees and putting. Treating Cuts the Right WayOne of the most important things to know about first aid for cuts is when to get help. But many minor cuts can be treated at home. Its important to clean the wound, apply pressure to stop the bleeding, and cover the wound to prevent infection….Read the Full Story

Related posts:

1. One step closer to turning off cancer genes with gene-silencing – UQ News Online – The University of Queensland
2. Britains First Swine-flu Trials Under Way
3. University Of The Basque Country Researcher Studies Genes Associated With Celiac Disease

Healthy middle-aged men and women with higher blood levels of DHA (docosahexaenonic acid), a type of omega-3 fatty acid, perform better on tests of reasoning, memory, and vocabulary.

More…